UCSF Search Toolbar
UCSF Radiation Oncology
Search
Doctor's Picture

Sue S. Yom

M.D., Ph.D.

Associate Professor, Departments of Radiation Oncology & Otolaryngology-Head and Neck Surgery

Helen Diller Family Comprehensive Cancer Center
Box 1708, 1600 Divisadero St, MZ Bldg R H1031
San Francisco, CA 94143 - 1708
Phone: 415-353-9893
Fax: 415-353-9883
Email: yoms [at] radonc.ucsf.edu

Professional Focus

Dr. Yom is a radiation oncologist who specializes in the treatment of head and neck, skin and thoracic cancers. She is particularly interested in understanding biologic pathways which have impact on the efficacy of radiation therapy and emerging radiotherapeutic and biologic techniques aimed at reducing the toxicities of treatment. In head and neck and skin cancer, she has studied a variety of issues related to chemoradiation and combined modality treatments, technical aspects of radiation delivery, and radiation-related prognostic factors and post-treatment management. Specifically in lung cancer, she has been involved in efforts to quantify the risks of pneumonitis and esophagitis resulting from concurrent treatment with chemotherapy and radiation and established parameters for using intensity-modulated radiation therapy in the treatment of locoregionally advanced lung cancers. She is experienced with many rare tumor types in the head and neck, cutaneous, and thoracic regions.

Dr. Yom is currently participating in a number of studies at UCSF addressing a variety of issues related to image-guided radiation, patients’ quality of life, and combinations of novel systemic agents with radiation therapy. She is especially interested in improved clinical and translational prognostic models in order to provide more efficacious and personalized cancer therapy. She is committed to UCSF’s tradition of technical innovation and provides consultation for her patients drawing from a wide range of radiotherapy techniques, to produce the best individualized plan for each patient. It is hoped that the continuous optimization of radiotherapy practice and the reduction of toxicities, both through technical and biologic means, will improve quality of life and enable physicians to deliver more intelligently targeted treatments in search of a better chance of cure. She believes in multidisciplinary management and a unified, team-oriented approach to patient care.